Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898026627> ?p ?o ?g. }
- W2898026627 endingPage "4340" @default.
- W2898026627 startingPage "4330" @default.
- W2898026627 abstract "Worldwide, more than one million people die each year from hepatitis C virus (HCV) related diseases, and over 300 million people are chronically infected with hepatitis B or C. Egypt used to be on the top of the countries with heavy HCV burden. Some countries are making advances in elimination of HCV, yet multiple factors preventing progress; remain for the majority. These factors include lack of global funding sources for treatment, late diagnosis, poor data, and inadequate screening. Treatment of HCV in Egypt has become one of the top national priorities since 2007. Egypt started a national treatment program intending to provide cure for Egyptian HCV-infected patients. Mass HCV treatment program had started using Pegylated interferon and ribavirin between 2007 and 2014. Yet, with the development of highly-effective direct acting antivirals (DAAs) for HCV, elimination of viral hepatitis has become a real possibility. The Egyptian National Committee for the Control of Viral Hepatitis did its best to provide Egyptian HCV patients with DAAs. Egypt adopted a strategy that represents a model of care that could help other countries with high HCV prevalence rate in their battle against HCV. This review covers the effects of HCV management in Egyptian real life settings and the outcome of different treatment protocols. Also, it deals with the current and future strategies for HCV prevention and screening as well as the challenges facing HCV elimination and the prospect of future eradication of HCV." @default.
- W2898026627 created "2018-10-26" @default.
- W2898026627 creator A5001839106 @default.
- W2898026627 creator A5025384297 @default.
- W2898026627 creator A5028444902 @default.
- W2898026627 creator A5032840404 @default.
- W2898026627 creator A5033360798 @default.
- W2898026627 creator A5036630649 @default.
- W2898026627 creator A5055514701 @default.
- W2898026627 creator A5060463525 @default.
- W2898026627 creator A5060976057 @default.
- W2898026627 creator A5061692975 @default.
- W2898026627 creator A5074690520 @default.
- W2898026627 creator A5076862709 @default.
- W2898026627 creator A5088446824 @default.
- W2898026627 date "2018-10-14" @default.
- W2898026627 modified "2023-10-10" @default.
- W2898026627 title "Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations" @default.
- W2898026627 cites W1533776211 @default.
- W2898026627 cites W1571473046 @default.
- W2898026627 cites W1594992171 @default.
- W2898026627 cites W1602075152 @default.
- W2898026627 cites W1821706753 @default.
- W2898026627 cites W1830384610 @default.
- W2898026627 cites W1943649358 @default.
- W2898026627 cites W1963967527 @default.
- W2898026627 cites W1973144315 @default.
- W2898026627 cites W1974879228 @default.
- W2898026627 cites W1975119554 @default.
- W2898026627 cites W1979179908 @default.
- W2898026627 cites W1979959585 @default.
- W2898026627 cites W2019263347 @default.
- W2898026627 cites W2030969088 @default.
- W2898026627 cites W2036599322 @default.
- W2898026627 cites W2037648619 @default.
- W2898026627 cites W2046844674 @default.
- W2898026627 cites W2052045757 @default.
- W2898026627 cites W2068705922 @default.
- W2898026627 cites W2088739494 @default.
- W2898026627 cites W2096347191 @default.
- W2898026627 cites W2098366795 @default.
- W2898026627 cites W2101258310 @default.
- W2898026627 cites W2112996757 @default.
- W2898026627 cites W2115486081 @default.
- W2898026627 cites W2116187238 @default.
- W2898026627 cites W2130525876 @default.
- W2898026627 cites W2132171038 @default.
- W2898026627 cites W2133036275 @default.
- W2898026627 cites W2145595073 @default.
- W2898026627 cites W2152811487 @default.
- W2898026627 cites W2160537948 @default.
- W2898026627 cites W2163692778 @default.
- W2898026627 cites W2165227114 @default.
- W2898026627 cites W2165705773 @default.
- W2898026627 cites W2180764485 @default.
- W2898026627 cites W2184943314 @default.
- W2898026627 cites W2301070161 @default.
- W2898026627 cites W2410976255 @default.
- W2898026627 cites W2416811162 @default.
- W2898026627 cites W2417431402 @default.
- W2898026627 cites W2419283364 @default.
- W2898026627 cites W2442225684 @default.
- W2898026627 cites W245509987 @default.
- W2898026627 cites W2485199946 @default.
- W2898026627 cites W2527863729 @default.
- W2898026627 cites W2566434209 @default.
- W2898026627 cites W2569547219 @default.
- W2898026627 cites W2578013986 @default.
- W2898026627 cites W2583841702 @default.
- W2898026627 cites W2615797938 @default.
- W2898026627 cites W2756980462 @default.
- W2898026627 cites W2761789646 @default.
- W2898026627 cites W2765365186 @default.
- W2898026627 cites W2769703277 @default.
- W2898026627 cites W2771909039 @default.
- W2898026627 cites W2781686734 @default.
- W2898026627 cites W2785078610 @default.
- W2898026627 cites W2789393147 @default.
- W2898026627 cites W2791381610 @default.
- W2898026627 cites W2794606856 @default.
- W2898026627 cites W2802214863 @default.
- W2898026627 cites W2804231560 @default.
- W2898026627 cites W2805340896 @default.
- W2898026627 cites W4300882633 @default.
- W2898026627 doi "https://doi.org/10.3748/wjg.v24.i38.4330" @default.
- W2898026627 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6189850" @default.
- W2898026627 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30344418" @default.
- W2898026627 hasPublicationYear "2018" @default.
- W2898026627 type Work @default.
- W2898026627 sameAs 2898026627 @default.
- W2898026627 citedByCount "97" @default.
- W2898026627 countsByYear W28980266272019 @default.
- W2898026627 countsByYear W28980266272020 @default.
- W2898026627 countsByYear W28980266272021 @default.
- W2898026627 countsByYear W28980266272022 @default.
- W2898026627 countsByYear W28980266272023 @default.
- W2898026627 crossrefType "journal-article" @default.
- W2898026627 hasAuthorship W2898026627A5001839106 @default.